AI assistant
UNITED THERAPEUTICS Corp — Director's Dealing 2021
Nov 18, 2021
30320_dirs_2021-11-18_ccf89b86-9fc8-48f3-990f-49e3a70308c1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2021-11-18
Reporting Person: MAHON PAUL A (EVP & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-18 | Common Stock | M | 6000 | $111.00 | Acquired | 42369 | Direct |
| 2021-11-18 | Common Stock | D | 200 | $197.775 | Disposed | 42169 | Direct |
| 2021-11-18 | Common Stock | D | 5200 | $199.316 | Disposed | 36969 | Direct |
| 2021-11-18 | Common Stock | D | 600 | $199.9317 | Disposed | 36369 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-18 | Stock Options | $111.00 | M | 6000 | Disposed | 2028-03-15 | Common Stock (6000) | Direct |
Footnotes
F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
F2: This transaction was executed in multiple trades at prices ranging from $197.53 to 198.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $198.77 to 199.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $199.78 to 200.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.